Richards Allen L
Rickettsial Diseases Department, Naval Medical Research Center, RDD/IDD Rm 3S04B, 503 Robert Grant Avenue, Silver Spring, MD 20910-7500, USA.
Expert Rev Vaccines. 2004 Oct;3(5):541-55. doi: 10.1586/14760584.3.5.541.
In the past century vaccine development for prevention of rickettsial diseases has been prolific. However, in the past 20 years no new rickettsial vaccine has been manufactured and there are currently no new or old rickettsial vaccines licensed. Early rickettsial vaccines were difficult, expensive and very hazardous to produce. Molecular biology techniques of today are currently being used to develop new rickettsial vaccines that are standardized, inexpensive, nonhazardous and efficacious.
在过去的一个世纪里,用于预防立克次氏体病的疫苗研发成果丰硕。然而,在过去20年里,没有新的立克次氏体疫苗被生产出来,目前也没有新的或旧的立克次氏体疫苗获得许可。早期的立克次氏体疫苗生产困难、成本高昂且极具危险性。当今的分子生物学技术正被用于研发标准化、低成本、无危害且有效的新型立克次氏体疫苗。